标题
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 15, Issue 8, Pages 1133-1146
出版商
Informa UK Limited
发表日期
2016-06-09
DOI
10.1080/14740338.2016.1199683
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease
- (2015) J. Michael Wells et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Roflumilast in COPD
- (2015) Erin Worndl et al. CHEST
- Roflumilast: A Review in COPD
- (2015) Karly P. Garnock-Jones DRUGS
- Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease
- (2015) Maria Gabriella Matera et al. Expert Opinion On Drug Safety
- Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial
- (2015) Fernando J Martinez et al. LANCET
- Drug-induced secretory diarrhea: A role for CFTR
- (2015) Changsuk Moon et al. PHARMACOLOGICAL RESEARCH
- Roflumilast added to triple therapy in patients with severe COPD: A real life study
- (2015) Mariana Muñoz-Esquerre et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
- (2015) Yin Wan et al. International Journal of Chronic Obstructive Pulmonary Disease
- Closing the Gap between Methodologists and End-Users:Ras a Computational Back-End
- (2015) Byron C. Wallace et al. Journal of Statistical Software
- Diabetes mellitus among outpatients with COPD attending a university hospital
- (2014) Paola Rogliani et al. ACTA DIABETOLOGICA
- Counterpoint: Were Industry-Sponsored Roflumilast Trials Appropriate? No
- (2014) Jason Rho et al. CHEST
- Point: Were Industry-Sponsored Roflumilast Trials Appropriate? Yes
- (2014) Samy Suissa et al. CHEST
- Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
- (2014) Maria Gabriella Matera et al. DRUGS
- Defining Phenotypes in COPD: An Aid to Personalized Healthcare
- (2014) Andrea Segreti et al. Molecular Diagnosis & Therapy
- Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases
- (2013) Bianca Beghè et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cystic Fibrosis Transmembrane Conductance Regulator Activation by Roflumilast Contributes to Therapeutic Benefit in Chronic Bronchitis
- (2013) James A. Lambert et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
- (2013) William B. White et al. CHEST
- Roflumilast for the Treatment of COPD in an Asian Population
- (2013) Jinping Zheng et al. CHEST
- Discovery and Development of Antisecretory Drugs for Treating Diarrheal Diseases
- (2013) Jay R. Thiagarajah et al. Clinical Gastroenterology and Hepatology
- Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD
- (2013) Donald P Tashkin EXPERT OPINION ON PHARMACOTHERAPY
- Application of population pharmacokinetic modeling to explore the impact of alternative roflumilast dosing regimens on tolerability
- (2013) Gezim Lahu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Meta-Methodology: Conducting and Reporting Meta-Analyses
- (2013) J. Rick Turner et al. Journal of Clinical Hypertension
- Retrieving Clinical Evidence: A Comparison of PubMed and Google Scholar for Quick Clinical Searches
- (2013) Salimah Z Shariff et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Efficacy and safety of roflumilast in patients with stable chronic obstructive pulmonary disease: A meta-analysis
- (2013) Jun-Hong Yan et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Benefits and harms of roflumilast in moderate to severe COPD
- (2013) Tsung Yu et al. THORAX
- Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
- (2013) Yevgeniy Samyshkin et al. International Journal of Chronic Obstructive Pulmonary Disease
- Response to: Oba, Y. and Lone, N. (2013) Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.Ther Adv Respir Dis 7: 13–24.
- (2013) Shahid Siddiqui Therapeutic Advances in Respiratory Disease
- Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas
- (2012) Weiqiang Zhang et al. Future Medicinal Chemistry
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Side-effects of roflumilast
- (2012) Steve Gupta LANCET
- Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
- (2012) Yuji Oba et al. Therapeutic Advances in Respiratory Disease
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
- (2011) Klaus F. Rabe BRITISH JOURNAL OF PHARMACOLOGY
- Physiological effects of roflumilast at rest and during exercise in COPD
- (2011) Denis E. O’Donnell et al. EUROPEAN RESPIRATORY JOURNAL
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis—A Simulation Study
- (2011) Kristian Thorlund et al. PLoS One
- Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study
- (2011) Mario Cazzola et al. RESPIRATORY MEDICINE
- Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial
- (2011) SANG-DO LEE et al. RESPIROLOGY
- Roflumilast in chronic obstructive pulmonary disease: evidence from large trials
- (2010) Mario Cazzola et al. EXPERT OPINION ON PHARMACOTHERAPY
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release
- (2009) WK Ong et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of AMP-activated protein kinase by cAMP in adipocytes: Roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis
- (2009) Bilal Omar et al. CELLULAR SIGNALLING
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- (2009) Leonardo M Fabbri et al. LANCET
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- (2009) Peter MA Calverley et al. LANCET
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
- (2009) Miles D. Houslay TRENDS IN BIOCHEMICAL SCIENCES
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More